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IgG4-associated orbital and ocular inflammation
Cecilia S Lee1,2, George J Harocopos1,3, Courtney L Kraus1,4, Aaron Y Lee1,5, Gregory P Van Stavern1,
Steven M Couch1 and P Kumar Rao1*

Abstract
Background: IgG4-associated orbital and ocular inflammation is a relatively unknown entity characterized by
sclerosing inflammation with infiltration of IgG4-positive plasma cells. Some so-called idiopathic inflammation
syndromes are being re-classified as IgG4-associated inflammation with histopathologic evaluation.
Findings: We report three cases with differing manifestations of IgG4-associated ocular and orbital inflammation:
a case of recurrent, treatment-refractory sclero-uveitis that was diagnosed as granulomatosis with polyangiitis with an
IgG4-related component, a case of pachymeningitis with optic neuritis that resulted in permanent visual loss, and a
case of orbital inflammatory pseudotumor. All three would have been incompletely diagnosed without thorough
histopathologic evaluation (including immunohistochemistry).
Conclusions: IgG4-associated disease is an idiopathic, multi-organ inflammatory state that can manifest as
chronic, relapsing, sclerosing inflammation in virtually any organ system. There is a wide range of presentations in
ocular and orbital inflammation. Ophthalmologists should keep IgG4-associated inflammation in mind when examining
chronic, sclerofibrosing inflammation with multi-system involvement. The histology of biopsy specimens is crucial in
making the correct diagnosis. Timely assessment may lead to fewer diagnostic tests and more targeted therapy.
Keywords: IgG4-associated ocular inflammation; IgG4-associated orbital inflammation; Histopathology

Findings
IgG4-associated disease is a relatively newly discovered
entity characterized by sclerosing inflammation, a lymphoplasmacytic infiltration full of IgG4-positive plasma
cells and frequently associated with elevated serum IgG4
concentrations [1]. It was first described as a systemic
condition in 2003 when extra-pancreatic manifestations
were identified in patients with autoimmune pancreatitis, a condition known to be associated with elevated
levels of IgG4 [2]. Since that discovery, the presence of
IgG4-related inflammation has been detected in virtually
all organs, particularly the pancreas, liver, kidney, lung,
and thyroid [1, 3, 4, 5]. The histopathological features
exhibit remarkable consistency across organ systems. In
ophthalmology, IgG4-positive sclerosing inflammation
most frequently presents with involvement of the orbit/
lacrimal gland [1, 5, 6], but recent case reports have
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described conjunctival and scleral involvement [3, 7]. We
report a series of three heterogeneous patients including
some unusual presentations of IgG4-associated ocular/
orbital inflammatory disease: sclero-uveitis, pachymeningitis with associated bilateral optic neuropathy/perineuritis,
and inflammatory pseudotumor of the orbit.
Case summaries
Case 1

A 79-year-old woman was referred to our institution
with a 1-year history of tearing, blurry vision, pain,
photophobia, and redness in her right eye. Past medical
history was significant for breast cancer, which required
right lumpectomy 14 years prior and left lumpectomy
plus radiation that was completed about 1 year prior to
referral. The patient’s symptoms in the right eye had
begun about 1 month following the completion of the
radiation treatment for breast cancer, at which point she
was diagnosed with nodular scleritis inferotemporally in
the right eye, and she was found to have elevated perinuclear accentuated anti-neutrophil cytoplasmic antibodies (p-ANCA), leading to suspicion for granulomatosis
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with polyangiitis. She was managed by multiple ophthalmologists and rheumatologists. Medical history also
included insulin-dependent diabetes, hypertension, hyperlipidemia, anemia, and colon cancer about 16 years prior.
There was a history of maxillary and sphenoid sinusitis,
for which the patient had right mastoid surgery, as well as
a history of bilateral ear tubes. The patient also had, at
the time of presentation, bilateral renal oncocytomas
treated with cryoablation, but renal function was normal.
Past ocular history included open-angle glaucoma initially
well-controlled with topical therapy alone but later exacerbated by an inflammatory/corticosteroid-induced component in the right eye. Prior to referral, the patient had
been treated with oral prednisone, with good response, but
experienced recurrences whenever the dose was tapered.
She had also been treated with cyclophosphamide and indomethacin but had a history of poor response to azathioprine.
Upon referral to our institution, best corrected visual acuity
(BCVA) was 20/80 in the right eye. Slit-lamp examination
demonstrated 360° of conjunctival and scleral injection, nodules in the temporal sclera, and 1+ nuclear sclerotic cataract.
Dilated fundus examination and B-scan ultrasound showed
panuveitis and serous retinal detachment associated with
subretinal fluid (Fig. 1). A “T” sign was also noted on ultrasound, consistent with posterior scleritis. Left eye exam
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was unremarkable. The differential diagnosis included inflammatory sclero-uveitis and intraocular lymphoma but favoring a diagnosis of inflammatory anterior/posterior
scleritis and uveitis. An extensive work-up for sclerouveitis was only positive for p-ANCA with a titer of
>1:640 (normal <1:10). Pertinent negatives included
rheumatoid factor, rapid plasma reagin, fluorescent treponemal antibody, and angiotensin converting enzyme. The
leading diagnosis was granulomatosis with polyangiitis,
and the patient was treated with oral prednisone, cyclophosphamide, and indomethacin and showed clinical improvement, with vision improving to 20/40.
Nine months later, our patient was referred again with
an exacerbation of her inflammation after cataract surgery
in the right eye (performed at an outside institution). Her
BCVA was 20/200. Slit-lamp examination showed mild
scleral injection with a fibrotic-appearing lesion adherent
to the medial sclera. Dilated fundus examination demonstrated chorioretinal scars with subretinal fibrosis and pale
optic nerve. The infiltrative fibrotic lesion on the sclera
was biopsied, and histologic examination revealed mixed
chronic inflammatory infiltrate with fibrosis consistent
with orbital inflammatory pseudotumor (Fig. 1b–d). Although no actively necrotizing vasculitis was seen, a portion
of the inflammation exhibited a vasculo-centric pattern,

Fig. 1 a B-scan ultrasonography shows serous elevation of the retina in the right eye of case 1. b–d Histology of episcleral/orbital biopsy from
case 1. b Chronic inflammation in a background of fibrosis is seen. In this field, there is a vasculo-centric component to the inflammation (arrows),
along with a hyalinized vessel (arrowhead) (H&E stain, original magnification, ×200). c Higher magnification of another region exhibits mixed
chronic inflammatory cells, including lymphocytes, plasma cells, and macrophages (H&E stain, original magnification, ×600). d IgG4 immunostain was
positive in up to 50 plasma cells per high-power field, comprising over 50 % of the total plasma cell population (original magnification, ×400)
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with hyalinization of vessels, raising the possibility that
these findings represented the late stage of a vasculitic
process, and accordingly, granulomatosis with polyangiitis
remained in the differential diagnosis (Fig. 1b, c).
Treatment subsequently included methotrexate and
infliximab infusions, but the patient continued to have
recurrent eye pain and eventually developed a blind,
painful right eye with end-stage glaucoma and persistent
vitritis, besides evidence of optic nerve sheath inflammation on imaging, leading to an enucleation. The histopathology of the globe showed necrotizing and fibrotic
granulomatous scleritis and granulomatous panuveitis
(Fig. 2). Of note, microbial stains were negative. Chronic
optic neuritis was also noted, with optic cupping and atrophy (Fig. 2a, e). There was serous detachment of the
retina with subretinal protein, correlating with the clinical appearance (Fig. 2a). The retina exhibited severe atrophy, with chronic vasculitis seen in some of the retinal
vessels (Fig. 2f ), and a neovascular epiretinal membrane
was appreciated overlying the pars plana. There were no
atypical lymphocytes or any evidence of lymphoma on
immunohistochemistry, with T cells (CD3-positive) far
outnumbering the B cells (CD20-positive), and with in
situ hybridization demonstrating a relatively even mixture of kappa- and lambda-positive plasma cells (not
shown). Many of the plasma cells stained positive with
IgG4 (Fig. 2g), i.e., about 70 per high-power field, comprising over 50 % of the total plasma cell population.
(The total plasma cells were assessed with CD138 immunostain, not shown.) The previous episcleral/orbital
biopsy was then retrospectively also stained with IgG4
immunostain, which likewise revealed positivity in >50 %
of the plasma cell population (Fig. 1d). (Serum IgG4 was
not obtained.)
Case 2

A 54-year-old man with a 4-month history of recurrent
sinusitis, 100-lb unintentional weight loss, gait instability, and generalized weakness presented with headache
and painless, bilateral visual loss. Bilateral temporal artery biopsies were performed and showed no arteritis.
Magnetic resonance imaging (MRI) of the brain revealed
mild meningeal enhancement and a chronic subdural
hematoma causing mild midline shift. Following surgical
drainage, visual acuity remained unchanged, and his headaches worsened. Pertinent clinical findings were no light
perception in both eyes, amaurotic pupils, and bilateral
mild, temporal optic disc pallor. Ocular coherence tomography (OCT) of both optic nerves demonstrated normal
nerve fiber layer thickness. Laboratory tests failed to suggest an etiology of his vision loss. Lumbar puncture showed
lymphocytic pleocytosis but cytology and flow cytometry
were negative for lymphoma. Repeat brain MRI was
performed and demonstrated diffuse pachymeningeal
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enhancement (Fig. 3a) with possible involvement of the
optic nerve sheath (Fig. 3b); a dural biopsy was performed.
Histopathology demonstrated a dense infiltrate of lymphocytes and plasma cells, with no definite vasculitis or
granulomatous inflammation (Fig. 3c, d). The possibility
of marginal zone lymphoma was considered but was ruled
out by immunohistochemistry, with T cells (CD3-positive)
outnumbering B cells (CD20-positive), and with in situ
hybridization revealing a kappa:lambda ratio of <4:1 among
the plasma cells (not shown). In situ hybridization for
Epstein-Barr virus was negative (not shown). Additionally, molecular genetic studies did not show any evidence
of a clonal IgH gene rearrangement by polymerase chain
reaction (PCR). However, IgG4 immunostain was markedly positive, with 40 IgG4-positive cells per high-power
field (HPF), comprising over 40 % of the total plasma cell
population (Fig. 3e, f). (The total plasma cell population
was assessed with CD138 immunostain, and IgG immunostain was also obtained, showing that all IgG-positive
cells were also IgG4-positive, i.e., IgG4:IgG ratio of 1,
not shown). Subsequent bone marrow biopsy also showed
no evidence of lymphoma (small CD19-positive B-cell
population with normal kappa:lambda light chain ratio),
and fine-needle aspiration biopsy of a left supraclavicular lymph node showed similar findings negative for
lymphoma.
On his systemic work-up, p-ANCA was borderline positive, and serum IgG showed elevated IgG4 subclasses
(148.0; normal range 2.4–121.0). Accordingly, the diagnosis of IgG4-related meningeal disease was made. The patient was started on aggressive immunosuppression with
high-dose corticosteroids to be followed by either cyclophosphamide or rituximab. However, due to insurance issues, he was able to receive only methotrexate. There was
near-total resolution of meningeal enhancement on repeat
MRI, but his visual acuity improved to only bare light perception in both eyes. He remains stable on methotrexate
almost 1 year from his diagnosis.
Case 3

A 76-year old man with a history of bilateral lacrimal
gland masses and an otherwise unremarkable ocular
examination underwent left orbital biopsy at another institution. Clinical suspicion was high for possible lymphoma
due to the additional presence of cervical and axillary
lymphadenopathy. The histologic diagnosis at that time
was reactive lymphoid hyperplasia with fibrosis. Immunohistochemistry, kappa/lambda in situ hybridization, and
flow cytometry were negative for lymphoma. The patient
was lost to follow-up without any further work-up. He
presented a year later due to recurrence of orbital inflammation, at which point the surgeon requested histologic
work-up for IgG4-related disease. The slides from the
prior orbital biopsy were requested and reviewed, showing
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Fig. 2 (See legend on next page.)
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(See figure on previous page.)
Fig. 2 Histology of enucleated globe from case 1. a At low power, serous detachment with subretinal protein (p), uveitis (u) with choroidal
thickening, and scleritis (s) with scleral/episcleral thickening are appreciated. The abrupt defect in the episcleral fibrotic plaque medially
corresponds to the prior episcleral/orbital biopsy site (arrowhead). Optic nerve cupping is also evident. The gap in the eye wall where
the cornea would ordinarily be (c) is artifactual (H&E stain, original magnification, ×1). b Higher magnification of same region of globe
medially that was labeled in a. Besides the previously mentioned findings, episcleral/scleral fibrosis (f) is appreciated surrounding the
pockets of inflammation, corresponding to the fibrotic-appearing epsicleral/scleral plaque that was noted clinically (H&E stain, original
magnification, ×20). c Higher magnification reveals granulomatous uveitis (u), with several giant cells visible in the field (arrowheads).
Sclera (s) is visible at the bottom of the field (H&E stain, original magnification, ×200). d Higher magnification of sclera reveals necrotizing
and granulomatous scleritis, with both neutrophils (n) and macrophages including a giant cell (arrowhead) visible in the field (H&E stain,
original magnification, ×400). e Higher magnification of optic nerve, revealing peri-neuritis/neuritis, with chronic inflammatory cells infiltrating
both the optic nerve sheath (arrows) and pial septa within the optic nerve (arrowheads). Optic nerve cupping/atrophy is also seen (H&E stain, original
magnification, ×40). f Higher magnification of the retina reveals severe atrophy and exhibits the chronic vasculitis that was noted in some of the retinal
vessels (arrow) (H&E stain, original magnification, ×200). g IgG4 immunostain highlights >70 plasma cells per high-power field, corresponding
to >50 % of the plasma cell population, in the uvea and sclera/episclera. The uvea is captured in this field. The double-headed arrow
delineates the subretinal space (original magnification, ×400)

lymphoid follicles with intervening bands of fibrosis and
mixed chronic inflammatory cells. The tissue block was
also received, and additional sections were cut for CD138
and IgG4 immunostaining. There were at least 150–180
IgG4-positive plasma cells per high-power field, comprising over 40 % of the total plasma cell population (as
assessed by CD138). (Serum IgG4 was not obtained.) This
was considered consistent with IgG4-associated orbital inflammatory pseudotumor with sclerosing features. The
patient was initially treated with prednisone and then
transitioned to intravenous rituximab as first-line therapy
and had an excellent response with no recurrence at
2 years following therapy.

Discussion

IgG4-associated disease is a relatively newly described,
heterogeneous entity, initially described in autoimmune
pancreatitis. Hamano et al. found elevated serum IgG4
level in patients with autoimmune pancreatitis, and since
then, IgG4 has been used as an important marker to
diagnose and re-classify select disease states previously
regarded as idiopathic [8]. The disease is characterized
by IgG4-positive plasmacytic infiltrate, fibrosis of the involved organs, and often elevated serum IgG4 level.
Histologic analysis of biopsy specimens is critical in
diagnosing this condition [1]. IgG4-related disease tends
to affect people in the middle-aged to elderly years. The

Fig. 3 Neuroimaging and histopathology of Case 2. a T1 axial post-contrast image shows diffuse meningeal enhancement. b T1 post-contrast
sagittal image shows possible enhancement along right optic nerve sheath (arrow). c Histologic section of meninges, with arachnoid portion on
the left and dura on the right. A chronic inflammatory infiltrate is concentrated in the leptomeninges (H&E stain, original magnification, ×100).
d Higher magnification exhibits a mixed chronic inflammatory infiltrate, including abundant plasma cells (p), as well as lymphocytes (l) and macrophages
(m) (H&E stain, original magnification, ×400). e IgG4 immunostain highlights numerous plasma cells (original magnification, ×100). f Higher magnification
reveals >40 IgG4-positive plasma cells per high-power field, comprising about 40 % of the total plasma cell population (original magnification, ×400)
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most commonly involved sites are the pancreas, the salivary and lacrimal glands, and the orbit [9]. However,
the list of involved organs continues to grow with increasing awareness.
Immune disregulation has been hypothesized as the
most probable mechanism of IgG4-associated disease
[9]. IgG4 is only a minor component of four subsets of
IgG. The hypothesized pathogenesis involves upregulated expression of T-helper 2 cells; cytokines such as
interleukin-4,5, and 13; and regulatory cytokines such
as interleukin-10 and transforming growth factor-beta
[8, 10]. It has been suggested that this upregulation could
be due to repeat, prolonged exposure to specific antigens.
It is interesting to note that up to 40 % of patients with
IgG4-related disease suffer from allergic diseases such as
asthma or chronic sinusitis [11].
The treatment is mainly with oral corticosteroids, to
which the inflammation is generally exquisitely responsive; nevertheless, patients remain on long-term steroid
therapy, and relapse is common after cessation of corticosteroids [12]. Other therapies such as radiation or
immunomodulating agents are not well-described in the
literature [6]. A recent prospective, open-label trial of 30
patients using either rituximab alone (87 %) or combined
with corticosteroid for the first 2 months showed disease
response in 97 % of patients at month 6 [13]. Similar positive results from several smaller case series suggest that
rituximab should be considered in cases refractory to
corticosteroids and/or other disease-modifying antirheumatic drugs [14–16]. The authors suggest that B-cell depletion is an effective therapy in IgG4-associated disease,
thereby supporting the use of rituximab. Rituximab depletes CD20-positive B cells that differentiate into plasma
cells that produce IgG4 [14], and this can provide more
specific, targeted therapy in patients with IgG4-associated
disease.
Our first patient with necrotizing scleritis was refractory to oral corticosteroids and other immunomodulating agents such as methotrexate. Rituximab was not
tried given that its possibility of therapeutic advantage
was not known at the time of her treatment. The second
patient underwent slow prednisone taper with a maintenance dose of methotrexate; however, the vision had minimal improvement despite the quiescent disease activity.
Interestingly, only one of our patients (case 3) was treated
with rituximab and had an excellent outcome. Even though
rituximab was not an option due to insurance in case 2,
this would have been our therapy of choice.
Even though IgG4-related inflammation affects many
different organs, the histopathology is remarkably similar
in most cases, and this is critical in making the diagnosis. It should be noted, however, that besides the typical
fibro-inflammatory histologic picture generally seen in
IgG4-related disease, associations between granulomatous
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inflammatory diseases and IgG4 are also being discovered,
thereby broadening our understanding of the potential
scope of IgG4-related inflammation. For example, cases of
sarcoidosis, adult orbital xanthogranuloma, and granulomatosis with polyangiitis involving relatively high amounts
of IgG4-positive plasma cells on histology and/or elevated
IgG4 concentrations have all been recently reported [7,
17–20]. Interestingly, the necrotizing granulomatous inflammation on histology in our first case was evident only
in the enucleated globe but not in the prior episcleral biopsy. The episcleral biopsy for the most part fit the typical
histologic picture of IgG4-related disease, whereas the
enucleated globe revealed the overlap between granulomatous sclero-uveitis and IgG4-related inflammation in this
case. Accordingly, this case may be most properly diagnosed as granulomatosis with polyangiitis with an IgG4related component. There are two other case reports of
IgG4-related disease involving the episclera/sclera [3, 7].
In our case, the patient was much older than in the case
reported by Ohno et al. [3], but both patients had a fibroinflammatory mass lesion in the medial sclera. Their case
underwent enucleation due to patient’s choice in the setting of diagnostic uncertainty, while ours progressed to a
blind, painful eye despite aggressive immunosuppression.
There was also a history of uveitis in their case, but unlike
our case, no findings in the uvea were noted on histology
of the enucleated globe. In a case reported by Paulus et al.
[7], the patient was elderly, with a clinical presentation of
sclero-uveitis and elevated p-ANCA, as in our case. The
episcleral biopsy exhibited the typical histologic picture of
IgG4-related disease, but unlike our case, the globe was
not enucleated, so no histology of the uvea was available.
A series of granulomatosis with polyangiitis cases reported
by Chang et al. [20] found that cases involving the head
and neck (sinonasal/orbital) were the ones most likely to
exhibit an IgG4-related component on histology. Out of
the six cases with elevated p-ANCA, four involved the
sinonasal or orbital regions, and three of those four revealed an IgG4+/IgG+ plasma cell ratio of at least 30 %. It
has also been discovered that many of the ANCA antibodies in patients with granulomatosis with polyangiitis
are of the IgG4 subclass [21, 22].
Without the assistance of immunohistochemistry on
histopathology, our second patient would have been diagnosed as having idiopathic hypertrophic pachymeningitis,
and our third case would have been diagnosed as idiopathic
orbital inflammatory pseudotumor. There are several reported cases of IgG4-related sclerosing pachymeningitis,
and many of them were previously diagnosed as idiopathic
hypertrophic pachymeningitis [23–25]. Lindstrom et al.
[26] proposed a series of diagnostic criteria for IgG4related meningeal disease: high serum IgG and/or IgG4
levels, infiltration of IgG4-positive plasma cells into the lesion, involvement of other organs possibly involved in
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IgG4-associated disease, exclusion of other diseases associated with high-serum IgG4 levels (e.g., atopic dermatitis,
parasitic infections, pemphigus), exclusion of other diseases that could cause pachymeningitis, and good response
to corticosteroids. Our case met the majority of diagnostic
criteria except our patient had minimal response to steroids. Optic neuropathy in idiopathic hypertrophic pachymeningitis was shown to respond to therapy in six out of
eight affected patients described by Kupersmith et al. [27].
Our patient may not have responded because of the duration and extent of the disease process prior to treatment.
IgG4-related disease is an idiopathic, multi-organ inflammatory state that can manifest as chronic, relapsing
sclerosing inflammation in virtually any organ system.
Ocular/orbital manifestations include idiopathic orbital
inflammation, pachymeningitis, or sclero-uveitis. IgG4associated disease is an important diagnosis to make given
that it can guide more specific management. Making the
diagnosis prevents further extensive diagnostic testing and
multiple biopsies while allowing more specific and aggressive immunosuppression. Treatment may be different
depending on the involved organ systems. Systemic corticosteroids are generally the first-line therapy currently,
but rituximab can be combined or used as an alternative if
patients have contraindications to corticosteroids; furthermore, a shift toward rituximab as first-line therapy may be
seen in the future if more data on its success accumulate
[28]. Physicians should be familiar with the diagnosis and
be suspicious when patients present with chronic, sclerofibrosing inflammation with multi-systemic involvement.
As the understanding of this entity increases, more specific diagnostic criteria and treatment will likely develop.
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